Modulation of tumor microenvironment to hinder cancer progression and therapeutic resistance
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2211061
- Recipient
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $784,385
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Durham, NC 27708, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded Duke University a $784,385 Project Grant on September 30, 2022 to complete work by September 29, 2025. The grant supports the "Modulation of Tumor Microenvironment to Hinder Cancer Progression and Therapeutic Resistance" project under the Military Medical Research and Development program (CFDA 12.420).
This program aims to transform military and public health through innovative biomedical research solutions. Duke University will investigate medical approaches to modulate the tumor microenvironment and inhibit cancer progression and resistance to therapies. The university will apply the three-year grant funding to research developing treatments that alter the cellular environment surrounding tumors to impede cancer spread and overcome treatment resistance. Outcomes have potential to benefit both military service members and the general public.
Quick answers
Who received award W81XWH2211061?
W81XWH2211061 was awarded to Duke University by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2211061 worth?
$784,385 has been obligated on W81XWH2211061.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award